SCHEMBL1866920

SCHEMBL1866920

C[C@@H]1CC[C@H]2[C@@H]3C=CC4=CC(=N[N])C=C[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP17A1 P05093 1/20 0.49
▸ CYP19A1 P11511 11/20 0.46
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ PGR P06401 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ AR P10275 1/20 0.39
▸ CHRM1 P11229 1/20 0.39
▸ TBXA2R P21731 1/20 0.39
▸ ADRA1A P35348 1/20 0.39
▸ SRD5A2 P31213 1/20 0.33
▸ SHBG P04278 1/20 0.31
▸ NR3C1 P04150 1/20 0.31
▸ CHRM2 P08172 1/20 0.31
▸ OPRK1 P41145 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1861193 0.85 CYP17A1 (0.57) CYP17A1CYP19A1MEN1KMT2ACYP3A4
SCHEMBL1859964 0.80 CYP19A1 (0.46) CYP17A1CYP19A1MEN1KMT2ACYP3A4
SCHEMBL1858766 0.77 CYP17A1 (0.44) CYP17A1CYP19A1MEN1KMT2ACYP3A4
SCHEMBL1864911 0.75 CYP19A1 (0.53) CYP17A1CYP19A1MEN1KMT2ACYP3A4
SCHEMBL1858497 0.71 PGR (0.30) CYP3A4PGRALDH1A1CYP2C19AR
SCHEMBL23563828 0.71 PGR (0.71) CYP19A1MEN1KMT2ACYP3A4PGR
SCHEMBL11873485 0.71 CYP17A1 (0.69) CYP17A1CYP19A1MEN1KMT2ACYP3A4
SCHEMBL18767708 0.71 PGR (0.71) CYP19A1MEN1KMT2ACYP3A4PGR
SCHEMBL1859420 0.71 CYP17A1 (0.69) CYP17A1CYP19A1MEN1KMT2ACYP3A4
SCHEMBL18695522 0.71 CYP17A1 (0.69) CYP17A1CYP19A1MEN1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060154909-A1 1,4,6-androstatriene-3,17-dione (\"ATD\") for therapeutic uses KNELLER BRUCE W 2006-07-13 — — US claimed
US-7939517-B2 1,4,6-androstatriene-3,17-dione (“ATD”) for therapeutic uses KNELLER BRUCE W 2011-05-10 — — US disclosed
US-20060154909-A1 1,4,6-androstatriene-3,17-dione (\"ATD\") for therapeutic uses KNELLER BRUCE W 2006-07-13 — — US disclosed
Send feedback